- Advertisement -

CATEGORY

Today

Difelikefalin Safe, Effective for Kidney Disease-Associated Pruritus

Difelikefalin, an investigational intravenous (IV) drug for treating itch (pruritus) in patients with end-stage renal disease on hemodialysis,...

Type 1 Diabetes and Transgender Identity: Is There a Link?

The prevalence of type 1 diabetes among transgender and gender diverse patients is higher than in the general...

Riociguat an Option for Pulmonary Arterial Hypertension When PDE-5 Inhibitors Fail

NEW YORK (Reuters Health) - Patients with pulmonary arterial hypertension (PAH) at intermediate risk of death within a...

Anxious about going out into the world? You’re not alone, but there’s help

Claudia Finkelstein, Michigan State UniversityIt’s the moment we thought we were all waiting for…or is it?We were cautiously optimistic about the end of the...

New Side Effects With AstraZeneca and Janssen COVID-19 Vaccines?

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. ...

New EU Vaccine Probe Deepens Europe’s Covid Woes

Europe's stuttering vaccine rollout faced multiple hurdles on Friday as EU regulators said they were reviewing side effects of the Johnson & Johnson shot...

Latest news

Difelikefalin Safe, Effective for Kidney Disease-Associated Pruritus

Difelikefalin, an investigational intravenous (IV) drug for treating itch (pruritus) in patients with end-stage renal disease on hemodialysis,...

Type 1 Diabetes and Transgender Identity: Is There a Link?

The prevalence of type 1 diabetes among transgender and gender diverse patients is higher than in the general...
- Advertisement -